Tamoxifen in the treatment of breast cancer

N Engl J Med. 1998 Nov 26;339(22):1609-18. doi: 10.1056/NEJM199811263392207.

C K Osborne ¹

Affiliations

Affiliation

1 Department of Medicine, University of Texas Health Science Center at San Antonio, 78284-7884, USA.

PMID: 9828250 DOI: 10.1056/NEJM199811263392207

Products

Cat. No.

Product Name

Description

Target

Research Area
HY-13757A

Tamoxifen

99.92%, Estrogen Receptor Modulator

Estrogen Receptor/ERR; HSP; Autophagy; Apoptosis

Cancer
HY-13757

Tamoxifen Citrate

99.93%, Estrogen Receptor Modulator

Estrogen Receptor/ERR; HSP; Autophagy; Apoptosis

Cancer
HY-13757AS

Tamoxifen-d₅

99.99%, Estrogen Receptor Modulator

Estrogen Receptor/ERR; HSP; Autophagy; Apoptosis

Cancer
HY-13757S

Tamoxifen-d₃ hydrochloride

98.99%, Stable Isotope

Autophagy; HSP; Estrogen Receptor/ERR; Apoptosis; Isotope-Labeled Compounds

Cancer
HY-13757AS1

Tamoxifen-d₃

Stable Isotope

Estrogen Receptor/ERR; Apoptosis; Autophagy; HSP

Cancer
HY-13757R

Tamoxifen Citrate (Standard)

Estrogen Receptor Modulator

Estrogen Receptor/ERR; HSP; Autophagy; Apoptosis

Cancer

MedChemExpress Magic Cece

MedChemExpress: Contact Us; About Us; Headquarters; Distributors; Statement on False Report; Careers

Customer Support: Technical Support; Service; Ordering Information; Easy Return; Shipping Rates & Policies; Intellectual Property Promise

Resources: Free Sample; Resources; Molarity Calculator; Dilution Calculator; Terms & Conditions; Reconstitution Calculator; Specific Activity Calculator

Subscribe to our E-newsletter

Name
Email *

	Sorry, but the email address you supplied was invalid.

Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.

Copyright © 2013-2024 MedChemExpress. All Rights Reserved.: Site Map Privacy Policy

Join with us